Whilst WHO officials are yet to declare the ongoing coronavirus outbreak in Wuhan a global health emergency, China are taking preventative steps in the face of a growing and spreading caseload.READ MORE
In this guide, we explore what progenitor cells are, how they differ from stem cells, and their key properties that makes them useful in the body.READ MORE
In epidemiology, prevalence and incidence are among the most fundamental measures when it comes to monitoring disease. But do you know what they mean or how and why they are important? This article takes a look at disease prevalence and incidence, what this information tells us and how it can be used.READ MORE
With so many potential routes for food contaminants, both natural and otherwise, having the tools to detect them, determine the source of the problem and prevent them from reaching the consumer is therefore vitally important. In this article, we explore how 2DLC is being implemented to improve food safety and contaminant traceability.READ MORE
At first glance this question might seem like a no-brainer. Surely if you make an infectious disease notifiable then you are better able to contain infection and prevent it spreading, right? Unfortunately, whilst the principle seems simple, the reality is far less so. Here we take a look at the different facets and implications of making an infectious disease notifiable.
Wouldn't it be grand if it could be Christmas every day? Well, for one researcher, it sort of is. Meet Plant Pathologist and Extension Specialist Professor Gary Chastagner, also commonly referred to as "Mr Christmas Tree", a scientist who researches Christmas trees 365 days a year.READ MORE
"Biosecurity” encompasses a wide range of important topics, from bioterrorism to invasive alien species of both plants and animals. But for the purposes of this article, we are going to focus on the prevention of outbreaks of disease and how to minimize the spread when they do inevitably happen.READ MORE
When it comes to testing for infectious diseases, it seems some companies are engaged in a “race to the bottom” to provide the cheapest test possible. Ever-lower price points might be attractive for cash-strapped governments, NGOs and charities engaged in the ongoing fight against infectious diseases, but are such practices putting us at risk of compromising quality?READ MORE